New America Acquisition I Corp. (New York Stock Exchange:NWAX)
| Market Cap | $499.49M-1.8% |
| Revenue (ttm) | $0 |
| Net Income | $6.43M |
| EPS | $0.13 |
| Shares Out | 49.80M |
| PE Ratio | 76.22 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | 0.09 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About NWAX
New America Acquisition I Corp. is dedicated to finalizing a substantial business combination, which may take the form of a merger, an amalgamation, an exchange of shares, an asset acquisition, a share purchase, a corporate reorganization, or similar strategic alliance. Its target enterprises are primarily found within the technology, healthcare, and logistics industries. This entity was founded in 2025 and operates from its base in New York, New York.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$NWAX stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in NWAX holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by NWAX's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
NWAX Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New NWAX patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to NWAX from public contracts
Source: USAspending.gov
Bull Case vs Bear Case
AI-generated from NWAX’s recent data — informational, not investment advice
